drug injury - Leading Justice

New Ozempic Lawsuit Alleges Novo Nordisk Failed to Warn About Gastroparesis Side Effects

A growing number of individuals who have turned to Ozempic to manage their blood sugar levels or shed unwanted weight are now facing a new and debilitating challenge – severe stomach paralysis, also known as gastroparesis. As more and more people file lawsuits against the drug’s manufacturer, Novo Nordisk, a disturbing pattern has emerged, with […]

New Ozempic Lawsuit Alleges Novo Nordisk Failed to Warn About Gastroparesis Side Effects Read More »

Valsartan Lawsuit MDL: Latest Updates on Cancer-Related Claims

Product Liability / July 24, 2024 / 4 minutes of reading / By Faith Anderson / Bladder Cancer, blood pressure, Cancer, colorectal cancer, drug injury, drug injury lawsuit, esophageal cancer, high blood pressure, intestinal cancer, liver cancer, NDEA, NDMA, product liability lawsuit, prostate cancer, side effects, stomach cancer, valsartan, valsartan MDL, valsartan recall, valsartan settlement, valsartan update

Lawsuits over the alleged link between valsartan and cancer have raised serious concerns about the safety of this widely prescribed blood pressure medication. Reports of contamination with N-nitrosodimethylamine (NDMA), a potential carcinogen, have led to widespread recalls and a surge in legal claims. Patients who relied on valsartan, an angiotensin II receptor blocker (ARB), now

Valsartan Lawsuit MDL: Latest Updates on Cancer-Related Claims Read More »

Ozempic and Wegovy Linked to Severe Vision Loss in New Study

Product Liability / July 15, 2024 / 4 minutes of reading / By Faith Anderson / blindness, diabetes drug, diet drug, drug injury, drug injury lawsuit, gastrointestinal problems, gastroparesis, lawsuit, NAION, Nonarteritic anterior ischemic optic neuropathy, ozempic, semaglutide, side effects, stomach paralysis, vision loss, Wegovy, weight loss, weight loss drug

The popular diabetes and weight loss medications Ozempic and Wegovy, both containing the active ingredient semaglutide, have been hailed as revolutionary treatments in recent years. However, a new semaglutide study published this month in the medical journal JAMA Ophthalmology has uncovered a troubling connection between these popular drugs and a debilitating eye condition called nonarteritic

Ozempic and Wegovy Linked to Severe Vision Loss in New Study Read More »

Study Finds Side Effects of GLP-1 Drugs Could Cause Bone Density Loss

Product Liability / July 5, 2024 / 4 minutes of reading / By Faith Anderson / diabetes drug, diet drug, drug injury, drug injury lawsuit, gastrointestinal problems, gastroparesis, lawsuit, ozempic, semaglutide, side effects, stomach paralysis, Wegovy, weight loss, weight loss drug

A troubling new study has uncovered another potential side effect of Ozempic, Wegovy, Mounjaro, and other popular glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications. According to researchers, these in-demand treatments may be linked to a significant reduction in bone mineral density (BMD), potentially putting users at risk of osteoporosis and fractures. As the medical community

Study Finds Side Effects of GLP-1 Drugs Could Cause Bone Density Loss Read More »

New Lawsuit Alleges Novo Nordisk Failed to Warn About Gastroparesis Side Effects of Wegovy

Product Liability / July 5, 2024 / 4 minutes of reading / By Faith Anderson / diet drug, drug injury, drug injury lawsuit, gastrointestinal problems, gastroparesis, lawsuit, semaglutide, side effects, stomach paralysis, Wegovy, weight loss, weight loss drug

Wegovy, a higher-dose version of the widely used diabetes drug Ozempic, has gained significant popularity in recent years as a weight-loss aid. However, a growing number of individuals across the United States are now pursuing legal action against the manufacturer, Novo Nordisk, alleging that the company failed to adequately warn about the potential risks associated

New Lawsuit Alleges Novo Nordisk Failed to Warn About Gastroparesis Side Effects of Wegovy Read More »

Settlement Nearing for Valsartan Plaintiffs Suing Hetero, But Fight Continues Against Other Manufacturers

Product Liability / June 24, 2024 / 3 minutes of reading / By Faith Anderson / Bladder Cancer, blood pressure, Cancer, colorectal cancer, drug injury, drug injury lawsuit, esophageal cancer, high blood pressure, intestinal cancer, liver cancer, NDEA, NDMA, prostate cancer, side effects, stomach cancer, valsartan, valsartan recall, valsartan settlement

In a notable development in the ongoing valsartan litigation, lawyers are nearing a settlement agreement for those who sued Hetero, a manufacturer of the generic blood pressure medication that was tainted with carcinogenic impurities. This settlement, overseen by U.S. District Court Judge Renée M. Bumb in New Jersey, aims to provide relief to a subset

Settlement Nearing for Valsartan Plaintiffs Suing Hetero, But Fight Continues Against Other Manufacturers Read More »

Valsartan Litigation Update: Hetero Settles Personal Injury and Economic Loss Claims

Product Liability / June 13, 2024 / 4 minutes of reading / By Faith Anderson / Bladder Cancer, blood pressure, Cancer, colorectal cancer, drug injury, drug injury lawsuit, esophageal cancer, high blood pressure, intestinal cancer, liver cancer, NDMA, prostate cancer, settlement, settlement agreement, side effects, stomach cancer, valsartan, valsartan recall, valsartan settlement

One of the key players involved in the ongoing valsartan NDMA litigation has agreed to a settlement of valsartan lawsuits, providing some relief to individuals impacted by the contaminated blood pressure medication. The U.S. District Judge presiding over the valsartan lawsuits has been informed that a preliminary settlement agreement has been reached with Hetero Drugs,

Valsartan Litigation Update: Hetero Settles Personal Injury and Economic Loss Claims Read More »

Wegovy Gastroparesis Lawsuits: Patients Seek Compensation for Stomach Paralysis Injuries

Product Liability / May 17, 2024 / 4 minutes of reading / By Faith Anderson / diet drug, drug injury, drug injury lawsuit, gastrointestinal problems, gastroparesis, lawsuit, semaglutide, side effects, stomach paralysis, Wegovy, weight loss, weight loss drug

Despite the growing popularity of Novo Nordisk’s semaglutide-based Wegovy as a solution for weight loss, an alarming number of Wegovy users have reported severe gastrointestinal complications, including a debilitating condition known as gastroparesis. As patients struggle with the life-altering effects of gastroparesis, or stomach paralysis, many are considering legal claims, seeking compensation and accountability from

Wegovy Gastroparesis Lawsuits: Patients Seek Compensation for Stomach Paralysis Injuries Read More »

Ozempic Lawsuit: Iowa Man Seeks Justice for Devastating Health Problems

Product Liability / April 26, 2024 / 4 minutes of reading / By Faith Anderson / Diabetes, diabetes drug, drug injury, drug injury lawsuit, gastrointestinal problems, gastroparesis, lawsuit, necrotizing pancreatitis, ozempic, pancreatitis, semaglutide, side effects, stomach paralysis, weight loss, weight loss drug

An Iowa man has taken legal action against the manufacturers of Ozempic, a widely prescribed diabetes drug. In a product liability lawsuit filed last week in the U.S. District Court for the Northern District of Iowa, plaintiff Shawn Derrick alleges that Novo Nordisk and its subsidiaries failed to provide adequate warnings about the health risks

Ozempic Lawsuit: Iowa Man Seeks Justice for Devastating Health Problems Read More »

Lawsuits Over Ozempic, Other GLP-1 Drugs: Are Label Warnings Adequate?

Product Liability / April 22, 2024 / 4 minutes of reading / By Faith Anderson / drug injury, drug injury lawsuit, gallbladder, gallbladder disease, gallbladder removal, gastrointestinal problems, gastroparesis, lawsuit, ozempic, semaglutide, side effects, stomach paralysis

In recent years, millions of Americans have turned to medications like Ozempic, Wegovy, and Mounjaro, which belong to the class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RA), for weight loss and diabetes management. These drugs have been aggressively promoted by their manufacturers as safe and effective. However, a growing number of former

Lawsuits Over Ozempic, Other GLP-1 Drugs: Are Label Warnings Adequate? Read More »

Get A Free Consultation

Personal Injury Lawsuits

Lawsuit Consultation